University of Edinburgh Featured PhD Programmes
University of Sussex Featured PhD Programmes
University of Glasgow Featured PhD Programmes

Regulation of integrin function on Treg by PI3K

Department of Pathology

This project is no longer listed on and may not be available.

Click here to search for PhD studentship opportunities
Prof Klaus Okkenhaug No more applications being accepted Competition Funded PhD Project (UK Students Only)

About the Project

Regulatory T cells (Treg) are a major barrier against effective immunotherapy. We have previously shown that inhibiting PI3Kdelta shifts the balance of the immune system by preferentially inhibiting Treg. It remains unknown; however, exactly why tumour-associated Treg are particularly susceptible to PI3Kdelta inhibition. The successful applicant will test the hypothesis that a major function of PI3Kdelta in Tregs is to regulate the integrin LFA-1. We will determine how kinase-dead or hyperactive mutants of PI3Kdelta affect the recruitment and migration of Tregs within tumours.

Funding Notes

Funding* will cover the student’s stipend at the current Research Council rate and University Fees. The studentship will be funded for three years in the first instance subject to eligibility, with the possibility of additional funding in the fourth year depending on circumstances.

*The studentships are available to students who qualify for Home fees

Applications from ineligible candidates will not be considered.


The University values diversity and is committed to equality of opportunity.

The University has a responsibility to ensure that all employees are eligible to live and work in the UK.


Ali, Khaled, Dalya R. Soond, Roberto Pineiro, Thorsten Hagemann, Wayne Pearce, Ee Lyn Lim, Hicham Bouabe, et al. ‘Inactivation of PI(3)K P110δ Breaks Regulatory T-Cell-Mediated Immune Tolerance to Cancer’. Nature 510, no. 7505 (19 2014): 407–11.
Garçon, Fabien, and Klaus Okkenhaug. ‘PI3Kδ Promotes CD4(+) T-Cell Interactions with Antigen-Presenting Cells by IncreasingLFA-1 Binding to ICAM-1’. Immunology and Cell Biology 94, no. 5(2016): 486–95.
Lim, Ee Lyn, Fiorella M. Cugliandolo, Dalya R. Rosner, David Gyori, Rahul Roychoudhuri, and Klaus Okkenhaug. ‘Phosphoinositide 3-Kinase δ Inhibition Promotes Antitumor Responses but Antagonizes Checkpoint Inhibitors’. JCI Insight 3, no. 11 (07 2018).
Search Suggestions

Search Suggestions

Based on your current searches we recommend the following search filters.

FindAPhD. Copyright 2005-2021
All rights reserved.